Ironwood Pharmaceuticals (IRWD)
NASDAQ:IRWD
Ironwood Pharma (IRWD) Ownership Overview
9.36% Insiders
15.03% Mutual Funds
25.10% Other Institutional Investors
17.57% ETFs
32.95% Public Companies and
Individual Investors
The ownership structure of Ironwood Pharma (IRWD) stock is a mix of institutional, retail, and individual investors. Approximately 57.69% of the company’s stock is owned by Institutional Investors, 9.36% is owned by Insiders, and 32.95% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Mar 17, 2026 | xxxxxxxxxxxxx | $20530448 | |
Feb 25, 2026 | xxxxxxxxxxxxx | $378905 | |
Feb 25, 2026 | xxxxxxxxxxxxx | $80328 | |
Feb 25, 2026 | xxxxxxxxxxxxx | $81888 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Dec 31, 2025 | xxxxxxxxxxxxx | $224526 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 9,444,944 | Insider | 5.79% | 28,712,630 | |
| 8,400,503 | Institution | 5.15% | 25,537,529 | |
| 7,320,283 | Institution | 4.49% | 22,253,660 | |
| 5,869,574 | Institution | 3.60% | 17,843,505 | |
| 4,111,632 | Institution | 2.52% | 12,499,361 | |
| 3,934,215 | Institution | 2.41% | 11,960,014 | |
| 3,143,912 | Institution | 1.93% | 9,557,492 | |
| 2,234,593 | Institution | 1.37% | 6,793,163 | |
| 2,014,790 | Institution | 1.24% | 6,124,962 | |
| 1,898,838 | Insider | 1.16% | 5,772,468 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 5,869,574 | Institution | 3.60% | 17,843,505 | |
| 3,143,912 | Institution | 1.93% | 9,557,492 | |
| 2,234,593 | Institution | 1.37% | 6,793,163 | |
| 2,014,790 | Institution | 1.24% | 6,124,962 | |
| 1,780,633 | Institution | 1.09% | 5,413,124 | |
| 1,437,510 | Institution | 0.88% | 4,370,030 | |
| 1,143,649 | Institution | 0.70% | 3,476,693 | |
| 936,168 | Institution | 0.57% | 2,845,951 | |
| 926,216 | Institution | 0.57% | 2,815,697 | |
| 906,782 | Institution | 0.56% | 2,756,617 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 4,334,784 | Institution | 2.66% | 14,824,961 | |
| 3,938,137 | Institution | 2.42% | 11,971,936 | |
| 3,176,911 | Institution | 1.95% | 10,261,423 | |
| 1,558,661 | Institution | 0.96% | 5,330,621 | |
| 1,225,548 | Institution | 0.75% | 3,725,666 | |
| 1,131,639 | Institution | 0.69% | 3,440,183 | |
| 1,084,497 | Institution | 0.67% | 3,502,925 | |
| 995,554 | Institution | 0.61% | 3,215,639 | |
| 995,554 | Institution | 0.61% | 3,215,639 | |
| 995,554 | Institution | 0.61% | 3,215,639 |
FAQ
Who Owns Ironwood Pharmaceuticals (IRWD)?
According to the latest TipRanks data, approximately 25.10% of the company's stock is held by institutional investors, 9.36% is held by insiders, and 32.95% is held by retail investors.
What percentage of Ironwood Pharmaceuticals (IRWD) stock is held by institutional investors?
According to the latest TipRanks data, approximately 25.10% of Ironwood Pharmaceuticals (IRWD) stock is held by institutional investors.
What percentage of Ironwood Pharmaceuticals (IRWD) stock is held by retail investors?
According to the latest TipRanks data, approximately 32.95% of Ironwood Pharmaceuticals (IRWD) stock is held by retail investors.
Who owns the most shares of Ironwood Pharmaceuticals (IRWD)?
Alexander Denner owns the most shares of Ironwood Pharmaceuticals (IRWD).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.